nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—ABCB1—melanoma	0.23	1	CbGaD
Boceprevir—CYP3A4—Temozolomide—melanoma	0.0578	0.318	CbGbCtD
Boceprevir—ABCB1—Dactinomycin—melanoma	0.0351	0.194	CbGbCtD
Boceprevir—CYP3A4—Vemurafenib—melanoma	0.0317	0.175	CbGbCtD
Boceprevir—CYP3A5—Docetaxel—melanoma	0.0279	0.154	CbGbCtD
Boceprevir—ABCB1—Docetaxel—melanoma	0.0181	0.0999	CbGbCtD
Boceprevir—CTSK—leg—melanoma	0.0123	0.0959	CbGeAlD
Boceprevir—CTSK—hindlimb—melanoma	0.011	0.0857	CbGeAlD
Boceprevir—CYP3A4—Docetaxel—melanoma	0.0109	0.0599	CbGbCtD
Boceprevir—CTSK—appendage—melanoma	0.00945	0.0735	CbGeAlD
Boceprevir—CTSV—hair follicle—melanoma	0.00911	0.0709	CbGeAlD
Boceprevir—CMA1—blood vessel—melanoma	0.00816	0.0635	CbGeAlD
Boceprevir—CTSK—hair follicle—melanoma	0.00561	0.0436	CbGeAlD
Boceprevir—CTSL—neck—melanoma	0.00499	0.0388	CbGeAlD
Boceprevir—CTSV—eye—melanoma	0.00455	0.0354	CbGeAlD
Boceprevir—CTSV—skin of body—melanoma	0.00396	0.0308	CbGeAlD
Boceprevir—CMA1—skin of body—melanoma	0.00378	0.0294	CbGeAlD
Boceprevir—CTSL—eye—melanoma	0.00372	0.0289	CbGeAlD
Boceprevir—CTSL—retina—melanoma	0.00368	0.0286	CbGeAlD
Boceprevir—CTSV—mammalian vulva—melanoma	0.00361	0.0281	CbGeAlD
Boceprevir—CMA1—mammalian vulva—melanoma	0.00345	0.0268	CbGeAlD
Boceprevir—CTSS—neck—melanoma	0.0033	0.0256	CbGeAlD
Boceprevir—CTSL—skin of body—melanoma	0.00323	0.0251	CbGeAlD
Boceprevir—CTSL—mammalian vulva—melanoma	0.00295	0.0229	CbGeAlD
Boceprevir—CTSK—eye—melanoma	0.0028	0.0218	CbGeAlD
Boceprevir—CTSK—retina—melanoma	0.00277	0.0216	CbGeAlD
Boceprevir—CTSV—head—melanoma	0.00258	0.0201	CbGeAlD
Boceprevir—CTSK—skin of body—melanoma	0.00244	0.0189	CbGeAlD
Boceprevir—CTSS—retina—melanoma	0.00243	0.0189	CbGeAlD
Boceprevir—CTSK—mammalian vulva—melanoma	0.00222	0.0173	CbGeAlD
Boceprevir—CTSS—skin of body—melanoma	0.00213	0.0166	CbGeAlD
Boceprevir—CTSL—head—melanoma	0.00211	0.0164	CbGeAlD
Boceprevir—CTSS—mammalian vulva—melanoma	0.00195	0.0151	CbGeAlD
Boceprevir—Telaprevir—ALB—melanoma	0.00185	0.512	CrCbGaD
Boceprevir—Telaprevir—ABCB1—melanoma	0.00176	0.488	CrCbGaD
Boceprevir—CMA1—lymph node—melanoma	0.00173	0.0134	CbGeAlD
Boceprevir—CTSK—head—melanoma	0.00159	0.0124	CbGeAlD
Boceprevir—CTSL—lymph node—melanoma	0.00148	0.0115	CbGeAlD
Boceprevir—CTSS—head—melanoma	0.00139	0.0108	CbGeAlD
Boceprevir—CTSK—lymph node—melanoma	0.00111	0.00865	CbGeAlD
Boceprevir—CTSS—lymph node—melanoma	0.000975	0.00758	CbGeAlD
Boceprevir—ABCB1—blood vessel—melanoma	0.000813	0.00632	CbGeAlD
Boceprevir—ABCB1—retina—melanoma	0.000429	0.00333	CbGeAlD
Boceprevir—ABCB1—mammalian vulva—melanoma	0.000343	0.00267	CbGeAlD
Boceprevir—Erythema—Dactinomycin—melanoma	0.000332	0.00167	CcSEcCtD
Boceprevir—Pain in extremity—Docetaxel—melanoma	0.000332	0.00167	CcSEcCtD
Boceprevir—Flushing—Carmustine—melanoma	0.000331	0.00167	CcSEcCtD
Boceprevir—Ill-defined disorder—Bleomycin—melanoma	0.00033	0.00166	CcSEcCtD
Boceprevir—Anaemia—Bleomycin—melanoma	0.000329	0.00165	CcSEcCtD
Boceprevir—Diarrhoea—Vemurafenib—melanoma	0.000328	0.00165	CcSEcCtD
Boceprevir—Migraine—Docetaxel—melanoma	0.000326	0.00164	CcSEcCtD
Boceprevir—Erythema multiforme—Temozolomide—melanoma	0.000326	0.00164	CcSEcCtD
Boceprevir—Eye disorder—Temozolomide—melanoma	0.000322	0.00162	CcSEcCtD
Boceprevir—Tinnitus—Temozolomide—melanoma	0.000322	0.00162	CcSEcCtD
Boceprevir—Malaise—Bleomycin—melanoma	0.000321	0.00161	CcSEcCtD
Boceprevir—Cardiac disorder—Temozolomide—melanoma	0.00032	0.00161	CcSEcCtD
Boceprevir—Flushing—Temozolomide—melanoma	0.00032	0.00161	CcSEcCtD
Boceprevir—Arrhythmia—Carmustine—melanoma	0.000319	0.0016	CcSEcCtD
Boceprevir—Leukopenia—Bleomycin—melanoma	0.000319	0.0016	CcSEcCtD
Boceprevir—Dizziness—Vemurafenib—melanoma	0.000317	0.00159	CcSEcCtD
Boceprevir—Alopecia—Carmustine—melanoma	0.000315	0.00159	CcSEcCtD
Boceprevir—Angiopathy—Temozolomide—melanoma	0.000313	0.00157	CcSEcCtD
Boceprevir—Mental disorder—Carmustine—melanoma	0.000313	0.00157	CcSEcCtD
Boceprevir—Immune system disorder—Temozolomide—melanoma	0.000312	0.00157	CcSEcCtD
Boceprevir—Mediastinal disorder—Temozolomide—melanoma	0.000311	0.00156	CcSEcCtD
Boceprevir—Malnutrition—Carmustine—melanoma	0.000311	0.00156	CcSEcCtD
Boceprevir—Erythema—Carmustine—melanoma	0.000311	0.00156	CcSEcCtD
Boceprevir—Cough—Bleomycin—melanoma	0.000311	0.00156	CcSEcCtD
Boceprevir—Chills—Temozolomide—melanoma	0.000309	0.00156	CcSEcCtD
Boceprevir—Dehydration—Docetaxel—melanoma	0.000308	0.00155	CcSEcCtD
Boceprevir—Ill-defined disorder—Dactinomycin—melanoma	0.000308	0.00155	CcSEcCtD
Boceprevir—Anaemia—Dactinomycin—melanoma	0.000307	0.00154	CcSEcCtD
Boceprevir—Vomiting—Vemurafenib—melanoma	0.000305	0.00153	CcSEcCtD
Boceprevir—Alopecia—Temozolomide—melanoma	0.000305	0.00153	CcSEcCtD
Boceprevir—Dry skin—Docetaxel—melanoma	0.000304	0.00153	CcSEcCtD
Boceprevir—Chest pain—Bleomycin—melanoma	0.000303	0.00152	CcSEcCtD
Boceprevir—Myalgia—Bleomycin—melanoma	0.000303	0.00152	CcSEcCtD
Boceprevir—Abdominal pain upper—Docetaxel—melanoma	0.000303	0.00152	CcSEcCtD
Boceprevir—Rash—Vemurafenib—melanoma	0.000302	0.00152	CcSEcCtD
Boceprevir—Mental disorder—Temozolomide—melanoma	0.000302	0.00152	CcSEcCtD
Boceprevir—Dermatitis—Vemurafenib—melanoma	0.000302	0.00152	CcSEcCtD
Boceprevir—Back pain—Carmustine—melanoma	0.000301	0.00151	CcSEcCtD
Boceprevir—Headache—Vemurafenib—melanoma	0.0003	0.00151	CcSEcCtD
Boceprevir—Erythema—Temozolomide—melanoma	0.0003	0.00151	CcSEcCtD
Boceprevir—Malnutrition—Temozolomide—melanoma	0.0003	0.00151	CcSEcCtD
Boceprevir—Breast disorder—Docetaxel—melanoma	0.0003	0.00151	CcSEcCtD
Boceprevir—Discomfort—Bleomycin—melanoma	0.000299	0.00151	CcSEcCtD
Boceprevir—Malaise—Dactinomycin—melanoma	0.000299	0.00151	CcSEcCtD
Boceprevir—Leukopenia—Dactinomycin—melanoma	0.000297	0.00149	CcSEcCtD
Boceprevir—Nasopharyngitis—Docetaxel—melanoma	0.000296	0.00149	CcSEcCtD
Boceprevir—Dysgeusia—Temozolomide—melanoma	0.000294	0.00148	CcSEcCtD
Boceprevir—Confusional state—Bleomycin—melanoma	0.000293	0.00147	CcSEcCtD
Boceprevir—Vision blurred—Carmustine—melanoma	0.000293	0.00147	CcSEcCtD
Boceprevir—Back pain—Temozolomide—melanoma	0.00029	0.00146	CcSEcCtD
Boceprevir—Infection—Bleomycin—melanoma	0.000289	0.00145	CcSEcCtD
Boceprevir—Anaemia—Carmustine—melanoma	0.000287	0.00144	CcSEcCtD
Boceprevir—Dysphagia—Docetaxel—melanoma	0.000287	0.00144	CcSEcCtD
Boceprevir—Agitation—Carmustine—melanoma	0.000286	0.00144	CcSEcCtD
Boceprevir—Nausea—Vemurafenib—melanoma	0.000285	0.00143	CcSEcCtD
Boceprevir—Thrombocytopenia—Bleomycin—melanoma	0.000284	0.00143	CcSEcCtD
Boceprevir—Vision blurred—Temozolomide—melanoma	0.000283	0.00142	CcSEcCtD
Boceprevir—Myalgia—Dactinomycin—melanoma	0.000283	0.00142	CcSEcCtD
Boceprevir—Discomfort—Dactinomycin—melanoma	0.000279	0.0014	CcSEcCtD
Boceprevir—Ill-defined disorder—Temozolomide—melanoma	0.000279	0.0014	CcSEcCtD
Boceprevir—Leukopenia—Carmustine—melanoma	0.000278	0.0014	CcSEcCtD
Boceprevir—Anaemia—Temozolomide—melanoma	0.000278	0.0014	CcSEcCtD
Boceprevir—Agitation—Temozolomide—melanoma	0.000276	0.00139	CcSEcCtD
Boceprevir—Angioedema—Temozolomide—melanoma	0.000274	0.00138	CcSEcCtD
Boceprevir—Pancytopenia—Docetaxel—melanoma	0.000272	0.00137	CcSEcCtD
Boceprevir—Hypotension—Bleomycin—melanoma	0.000271	0.00137	CcSEcCtD
Boceprevir—Malaise—Temozolomide—melanoma	0.000271	0.00136	CcSEcCtD
Boceprevir—Vertigo—Temozolomide—melanoma	0.00027	0.00136	CcSEcCtD
Boceprevir—Infection—Dactinomycin—melanoma	0.000269	0.00135	CcSEcCtD
Boceprevir—Leukopenia—Temozolomide—melanoma	0.000269	0.00135	CcSEcCtD
Boceprevir—Hypertension—Carmustine—melanoma	0.000268	0.00135	CcSEcCtD
Boceprevir—Neutropenia—Docetaxel—melanoma	0.000268	0.00135	CcSEcCtD
Boceprevir—Palpitations—Temozolomide—melanoma	0.000265	0.00133	CcSEcCtD
Boceprevir—Thrombocytopenia—Dactinomycin—melanoma	0.000265	0.00133	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Bleomycin—melanoma	0.000265	0.00133	CcSEcCtD
Boceprevir—Chest pain—Carmustine—melanoma	0.000265	0.00133	CcSEcCtD
Boceprevir—Myalgia—Carmustine—melanoma	0.000265	0.00133	CcSEcCtD
Boceprevir—Anxiety—Carmustine—melanoma	0.000264	0.00133	CcSEcCtD
Boceprevir—Cough—Temozolomide—melanoma	0.000262	0.00132	CcSEcCtD
Boceprevir—Paraesthesia—Bleomycin—melanoma	0.000261	0.00131	CcSEcCtD
Boceprevir—Weight decreased—Docetaxel—melanoma	0.000259	0.0013	CcSEcCtD
Boceprevir—Hypertension—Temozolomide—melanoma	0.000259	0.0013	CcSEcCtD
Boceprevir—Dyspnoea—Bleomycin—melanoma	0.000259	0.0013	CcSEcCtD
Boceprevir—Pneumonia—Docetaxel—melanoma	0.000257	0.00129	CcSEcCtD
Boceprevir—Confusional state—Carmustine—melanoma	0.000256	0.00129	CcSEcCtD
Boceprevir—Myalgia—Temozolomide—melanoma	0.000256	0.00129	CcSEcCtD
Boceprevir—Arthralgia—Temozolomide—melanoma	0.000256	0.00129	CcSEcCtD
Boceprevir—Infestation—Docetaxel—melanoma	0.000255	0.00129	CcSEcCtD
Boceprevir—Infestation NOS—Docetaxel—melanoma	0.000255	0.00129	CcSEcCtD
Boceprevir—Anxiety—Temozolomide—melanoma	0.000255	0.00128	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000254	0.00128	CcSEcCtD
Boceprevir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000253	0.00127	CcSEcCtD
Boceprevir—Discomfort—Temozolomide—melanoma	0.000253	0.00127	CcSEcCtD
Boceprevir—Decreased appetite—Bleomycin—melanoma	0.000253	0.00127	CcSEcCtD
Boceprevir—Infection—Carmustine—melanoma	0.000252	0.00127	CcSEcCtD
Boceprevir—Neuropathy peripheral—Docetaxel—melanoma	0.00025	0.00126	CcSEcCtD
Boceprevir—Dry mouth—Temozolomide—melanoma	0.00025	0.00126	CcSEcCtD
Boceprevir—Stomatitis—Docetaxel—melanoma	0.000249	0.00125	CcSEcCtD
Boceprevir—Pain—Bleomycin—melanoma	0.000248	0.00125	CcSEcCtD
Boceprevir—Conjunctivitis—Docetaxel—melanoma	0.000248	0.00125	CcSEcCtD
Boceprevir—Thrombocytopenia—Carmustine—melanoma	0.000248	0.00125	CcSEcCtD
Boceprevir—Tachycardia—Carmustine—melanoma	0.000247	0.00124	CcSEcCtD
Boceprevir—Confusional state—Temozolomide—melanoma	0.000247	0.00124	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000247	0.00124	CcSEcCtD
Boceprevir—ABCB1—head—melanoma	0.000246	0.00191	CbGeAlD
Boceprevir—Infection—Temozolomide—melanoma	0.000243	0.00122	CcSEcCtD
Boceprevir—Hepatobiliary disease—Docetaxel—melanoma	0.000242	0.00122	CcSEcCtD
Boceprevir—Epistaxis—Docetaxel—melanoma	0.000241	0.00121	CcSEcCtD
Boceprevir—Nervous system disorder—Temozolomide—melanoma	0.00024	0.00121	CcSEcCtD
Boceprevir—Thrombocytopenia—Temozolomide—melanoma	0.00024	0.00121	CcSEcCtD
Boceprevir—Feeling abnormal—Bleomycin—melanoma	0.000239	0.0012	CcSEcCtD
Boceprevir—Agranulocytosis—Docetaxel—melanoma	0.000238	0.0012	CcSEcCtD
Boceprevir—Skin disorder—Temozolomide—melanoma	0.000238	0.0012	CcSEcCtD
Boceprevir—Hypotension—Carmustine—melanoma	0.000237	0.00119	CcSEcCtD
Boceprevir—Hyperhidrosis—Temozolomide—melanoma	0.000237	0.00119	CcSEcCtD
Boceprevir—Decreased appetite—Dactinomycin—melanoma	0.000236	0.00118	CcSEcCtD
Boceprevir—Fatigue—Dactinomycin—melanoma	0.000234	0.00117	CcSEcCtD
Boceprevir—Pain—Dactinomycin—melanoma	0.000232	0.00117	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Carmustine—melanoma	0.000231	0.00116	CcSEcCtD
Boceprevir—Urticaria—Bleomycin—melanoma	0.000231	0.00116	CcSEcCtD
Boceprevir—Rhinitis—Docetaxel—melanoma	0.00023	0.00116	CcSEcCtD
Boceprevir—Body temperature increased—Bleomycin—melanoma	0.00023	0.00116	CcSEcCtD
Boceprevir—Insomnia—Carmustine—melanoma	0.000229	0.00115	CcSEcCtD
Boceprevir—Hypoaesthesia—Docetaxel—melanoma	0.000228	0.00115	CcSEcCtD
Boceprevir—Paraesthesia—Carmustine—melanoma	0.000228	0.00115	CcSEcCtD
Boceprevir—Pharyngitis—Docetaxel—melanoma	0.000228	0.00115	CcSEcCtD
Boceprevir—Urinary tract disorder—Docetaxel—melanoma	0.000227	0.00114	CcSEcCtD
Boceprevir—Dyspnoea—Carmustine—melanoma	0.000226	0.00114	CcSEcCtD
Boceprevir—Oedema peripheral—Docetaxel—melanoma	0.000226	0.00114	CcSEcCtD
Boceprevir—Connective tissue disorder—Docetaxel—melanoma	0.000225	0.00113	CcSEcCtD
Boceprevir—Urethral disorder—Docetaxel—melanoma	0.000225	0.00113	CcSEcCtD
Boceprevir—Feeling abnormal—Dactinomycin—melanoma	0.000223	0.00112	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Temozolomide—melanoma	0.000223	0.00112	CcSEcCtD
Boceprevir—Insomnia—Temozolomide—melanoma	0.000222	0.00111	CcSEcCtD
Boceprevir—Gastrointestinal pain—Dactinomycin—melanoma	0.000222	0.00111	CcSEcCtD
Boceprevir—Visual impairment—Docetaxel—melanoma	0.000221	0.00111	CcSEcCtD
Boceprevir—Decreased appetite—Carmustine—melanoma	0.00022	0.00111	CcSEcCtD
Boceprevir—Paraesthesia—Temozolomide—melanoma	0.00022	0.00111	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Carmustine—melanoma	0.000219	0.0011	CcSEcCtD
Boceprevir—Dyspnoea—Temozolomide—melanoma	0.000218	0.0011	CcSEcCtD
Boceprevir—Erythema multiforme—Docetaxel—melanoma	0.000217	0.00109	CcSEcCtD
Boceprevir—Constipation—Carmustine—melanoma	0.000217	0.00109	CcSEcCtD
Boceprevir—Pain—Carmustine—melanoma	0.000217	0.00109	CcSEcCtD
Boceprevir—Dyspepsia—Temozolomide—melanoma	0.000216	0.00108	CcSEcCtD
Boceprevir—Eye disorder—Docetaxel—melanoma	0.000214	0.00108	CcSEcCtD
Boceprevir—Abdominal pain—Dactinomycin—melanoma	0.000214	0.00108	CcSEcCtD
Boceprevir—Body temperature increased—Dactinomycin—melanoma	0.000214	0.00108	CcSEcCtD
Boceprevir—Hypersensitivity—Bleomycin—melanoma	0.000214	0.00108	CcSEcCtD
Boceprevir—Decreased appetite—Temozolomide—melanoma	0.000213	0.00107	CcSEcCtD
Boceprevir—Flushing—Docetaxel—melanoma	0.000213	0.00107	CcSEcCtD
Boceprevir—Cardiac disorder—Docetaxel—melanoma	0.000213	0.00107	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Temozolomide—melanoma	0.000212	0.00106	CcSEcCtD
Boceprevir—Fatigue—Temozolomide—melanoma	0.000211	0.00106	CcSEcCtD
Boceprevir—Constipation—Temozolomide—melanoma	0.00021	0.00105	CcSEcCtD
Boceprevir—Pain—Temozolomide—melanoma	0.00021	0.00105	CcSEcCtD
Boceprevir—Feeling abnormal—Carmustine—melanoma	0.000209	0.00105	CcSEcCtD
Boceprevir—Asthenia—Bleomycin—melanoma	0.000208	0.00105	CcSEcCtD
Boceprevir—Angiopathy—Docetaxel—melanoma	0.000208	0.00105	CcSEcCtD
Boceprevir—Gastrointestinal pain—Carmustine—melanoma	0.000207	0.00104	CcSEcCtD
Boceprevir—Immune system disorder—Docetaxel—melanoma	0.000207	0.00104	CcSEcCtD
Boceprevir—Mediastinal disorder—Docetaxel—melanoma	0.000207	0.00104	CcSEcCtD
Boceprevir—Chills—Docetaxel—melanoma	0.000206	0.00104	CcSEcCtD
Boceprevir—Pruritus—Bleomycin—melanoma	0.000206	0.00103	CcSEcCtD
Boceprevir—Arrhythmia—Docetaxel—melanoma	0.000205	0.00103	CcSEcCtD
Boceprevir—Alopecia—Docetaxel—melanoma	0.000203	0.00102	CcSEcCtD
Boceprevir—Feeling abnormal—Temozolomide—melanoma	0.000202	0.00102	CcSEcCtD
Boceprevir—Mental disorder—Docetaxel—melanoma	0.000201	0.00101	CcSEcCtD
Boceprevir—Abdominal pain—Carmustine—melanoma	0.0002	0.00101	CcSEcCtD
Boceprevir—Body temperature increased—Carmustine—melanoma	0.0002	0.00101	CcSEcCtD
Boceprevir—Gastrointestinal pain—Temozolomide—melanoma	0.0002	0.00101	CcSEcCtD
Boceprevir—Malnutrition—Docetaxel—melanoma	0.0002	0.001	CcSEcCtD
Boceprevir—Erythema—Docetaxel—melanoma	0.0002	0.001	CcSEcCtD
Boceprevir—Hypersensitivity—Dactinomycin—melanoma	0.0002	0.001	CcSEcCtD
Boceprevir—Dysgeusia—Docetaxel—melanoma	0.000196	0.000983	CcSEcCtD
Boceprevir—Urticaria—Temozolomide—melanoma	0.000195	0.000979	CcSEcCtD
Boceprevir—Asthenia—Dactinomycin—melanoma	0.000194	0.000978	CcSEcCtD
Boceprevir—Abdominal pain—Temozolomide—melanoma	0.000194	0.000974	CcSEcCtD
Boceprevir—Body temperature increased—Temozolomide—melanoma	0.000194	0.000974	CcSEcCtD
Boceprevir—Back pain—Docetaxel—melanoma	0.000193	0.000971	CcSEcCtD
Boceprevir—Muscle spasms—Docetaxel—melanoma	0.000192	0.000966	CcSEcCtD
Boceprevir—Hypersensitivity—Carmustine—melanoma	0.000187	0.00094	CcSEcCtD
Boceprevir—Diarrhoea—Dactinomycin—melanoma	0.000185	0.000932	CcSEcCtD
Boceprevir—Vomiting—Bleomycin—melanoma	0.000185	0.000929	CcSEcCtD
Boceprevir—Anaemia—Docetaxel—melanoma	0.000185	0.000928	CcSEcCtD
Boceprevir—Rash—Bleomycin—melanoma	0.000183	0.000921	CcSEcCtD
Boceprevir—Dermatitis—Bleomycin—melanoma	0.000183	0.00092	CcSEcCtD
Boceprevir—Asthenia—Carmustine—melanoma	0.000182	0.000915	CcSEcCtD
Boceprevir—Hypersensitivity—Temozolomide—melanoma	0.000181	0.000908	CcSEcCtD
Boceprevir—Syncope—Docetaxel—melanoma	0.000179	0.000901	CcSEcCtD
Boceprevir—Leukopenia—Docetaxel—melanoma	0.000179	0.000899	CcSEcCtD
Boceprevir—Palpitations—Docetaxel—melanoma	0.000176	0.000887	CcSEcCtD
Boceprevir—Asthenia—Temozolomide—melanoma	0.000176	0.000884	CcSEcCtD
Boceprevir—Loss of consciousness—Docetaxel—melanoma	0.000175	0.000883	CcSEcCtD
Boceprevir—Cough—Docetaxel—melanoma	0.000174	0.000876	CcSEcCtD
Boceprevir—Diarrhoea—Carmustine—melanoma	0.000173	0.000873	CcSEcCtD
Boceprevir—Pruritus—Temozolomide—melanoma	0.000173	0.000872	CcSEcCtD
Boceprevir—Nausea—Bleomycin—melanoma	0.000173	0.000868	CcSEcCtD
Boceprevir—Hypertension—Docetaxel—melanoma	0.000172	0.000867	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—melanoma	0.000172	0.000866	CcSEcCtD
Boceprevir—ABCB1—lymph node—melanoma	0.000172	0.00134	CbGeAlD
Boceprevir—Rash—Dactinomycin—melanoma	0.000171	0.000859	CcSEcCtD
Boceprevir—Myalgia—Docetaxel—melanoma	0.00017	0.000855	CcSEcCtD
Boceprevir—Arthralgia—Docetaxel—melanoma	0.00017	0.000855	CcSEcCtD
Boceprevir—Chest pain—Docetaxel—melanoma	0.00017	0.000855	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000169	0.000849	CcSEcCtD
Boceprevir—Dizziness—Carmustine—melanoma	0.000168	0.000843	CcSEcCtD
Boceprevir—Diarrhoea—Temozolomide—melanoma	0.000168	0.000843	CcSEcCtD
Boceprevir—Dry mouth—Docetaxel—melanoma	0.000166	0.000836	CcSEcCtD
Boceprevir—Confusional state—Docetaxel—melanoma	0.000164	0.000826	CcSEcCtD
Boceprevir—Dizziness—Temozolomide—melanoma	0.000162	0.000815	CcSEcCtD
Boceprevir—Infection—Docetaxel—melanoma	0.000162	0.000814	CcSEcCtD
Boceprevir—Vomiting—Carmustine—melanoma	0.000161	0.000811	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—melanoma	0.000161	0.000809	CcSEcCtD
Boceprevir—Shock—Docetaxel—melanoma	0.00016	0.000806	CcSEcCtD
Boceprevir—Rash—Carmustine—melanoma	0.00016	0.000804	CcSEcCtD
Boceprevir—Nervous system disorder—Docetaxel—melanoma	0.00016	0.000804	CcSEcCtD
Boceprevir—Dermatitis—Carmustine—melanoma	0.00016	0.000803	CcSEcCtD
Boceprevir—Thrombocytopenia—Docetaxel—melanoma	0.00016	0.000803	CcSEcCtD
Boceprevir—Tachycardia—Docetaxel—melanoma	0.000159	0.0008	CcSEcCtD
Boceprevir—Headache—Carmustine—melanoma	0.000159	0.000799	CcSEcCtD
Boceprevir—Skin disorder—Docetaxel—melanoma	0.000158	0.000796	CcSEcCtD
Boceprevir—Vomiting—Temozolomide—melanoma	0.000156	0.000784	CcSEcCtD
Boceprevir—Rash—Temozolomide—melanoma	0.000154	0.000777	CcSEcCtD
Boceprevir—Dermatitis—Temozolomide—melanoma	0.000154	0.000776	CcSEcCtD
Boceprevir—Headache—Temozolomide—melanoma	0.000154	0.000772	CcSEcCtD
Boceprevir—Hypotension—Docetaxel—melanoma	0.000152	0.000766	CcSEcCtD
Boceprevir—Nausea—Carmustine—melanoma	0.000151	0.000758	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Docetaxel—melanoma	0.000148	0.000747	CcSEcCtD
Boceprevir—Insomnia—Docetaxel—melanoma	0.000147	0.000741	CcSEcCtD
Boceprevir—Paraesthesia—Docetaxel—melanoma	0.000146	0.000736	CcSEcCtD
Boceprevir—Nausea—Temozolomide—melanoma	0.000146	0.000732	CcSEcCtD
Boceprevir—Dyspnoea—Docetaxel—melanoma	0.000145	0.000731	CcSEcCtD
Boceprevir—Dyspepsia—Docetaxel—melanoma	0.000143	0.000721	CcSEcCtD
Boceprevir—Decreased appetite—Docetaxel—melanoma	0.000142	0.000712	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Docetaxel—melanoma	0.000141	0.000708	CcSEcCtD
Boceprevir—Fatigue—Docetaxel—melanoma	0.00014	0.000707	CcSEcCtD
Boceprevir—Constipation—Docetaxel—melanoma	0.000139	0.000701	CcSEcCtD
Boceprevir—Pain—Docetaxel—melanoma	0.000139	0.000701	CcSEcCtD
Boceprevir—Feeling abnormal—Docetaxel—melanoma	0.000134	0.000675	CcSEcCtD
Boceprevir—Gastrointestinal pain—Docetaxel—melanoma	0.000133	0.00067	CcSEcCtD
Boceprevir—Abdominal pain—Docetaxel—melanoma	0.000129	0.000648	CcSEcCtD
Boceprevir—Body temperature increased—Docetaxel—melanoma	0.000129	0.000648	CcSEcCtD
Boceprevir—Hypersensitivity—Docetaxel—melanoma	0.00012	0.000604	CcSEcCtD
Boceprevir—Asthenia—Docetaxel—melanoma	0.000117	0.000588	CcSEcCtD
Boceprevir—Pruritus—Docetaxel—melanoma	0.000115	0.00058	CcSEcCtD
Boceprevir—Diarrhoea—Docetaxel—melanoma	0.000111	0.000561	CcSEcCtD
Boceprevir—Dizziness—Docetaxel—melanoma	0.000108	0.000542	CcSEcCtD
Boceprevir—Vomiting—Docetaxel—melanoma	0.000104	0.000521	CcSEcCtD
Boceprevir—Rash—Docetaxel—melanoma	0.000103	0.000517	CcSEcCtD
Boceprevir—Dermatitis—Docetaxel—melanoma	0.000103	0.000516	CcSEcCtD
Boceprevir—Headache—Docetaxel—melanoma	0.000102	0.000513	CcSEcCtD
Boceprevir—Nausea—Docetaxel—melanoma	9.68e-05	0.000487	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	2.79e-05	0.000109	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDKN1B—melanoma	2.79e-05	0.000108	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—melanoma	2.78e-05	0.000108	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGF—melanoma	2.78e-05	0.000108	CbGpPWpGaD
Boceprevir—CTSV—Immune System—STAT3—melanoma	2.77e-05	0.000108	CbGpPWpGaD
Boceprevir—CTSL—Immune System—STAT3—melanoma	2.77e-05	0.000108	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRAS—melanoma	2.76e-05	0.000107	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—melanoma	2.76e-05	0.000107	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—melanoma	2.76e-05	0.000107	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—melanoma	2.75e-05	0.000107	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	2.74e-05	0.000106	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL2—melanoma	2.73e-05	0.000106	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	2.69e-05	0.000104	CbGpPWpGaD
Boceprevir—CTSS—Immune System—FGF2—melanoma	2.69e-05	0.000104	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—melanoma	2.67e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACER3—melanoma	2.67e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—melanoma	2.65e-05	0.000103	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK3—melanoma	2.64e-05	0.000103	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK3—melanoma	2.64e-05	0.000103	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—BRAF—melanoma	2.64e-05	0.000103	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	2.64e-05	0.000103	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—melanoma	2.63e-05	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	2.59e-05	0.000101	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1—melanoma	2.57e-05	0.0001	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CDKN1A—melanoma	2.57e-05	0.0001	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PTEN—melanoma	2.57e-05	9.98e-05	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PIK3CA—melanoma	2.56e-05	9.95e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NFKB1—melanoma	2.55e-05	9.93e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—melanoma	2.55e-05	9.92e-05	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—melanoma	2.54e-05	9.87e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IFNG—melanoma	2.53e-05	9.82e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK1—melanoma	2.52e-05	9.79e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK1—melanoma	2.52e-05	9.79e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EGFR—melanoma	2.52e-05	9.79e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—EGFR—melanoma	2.52e-05	9.79e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MDM2—melanoma	2.51e-05	9.77e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAP2K1—melanoma	2.49e-05	9.67e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ERBB2—melanoma	2.48e-05	9.63e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CD—melanoma	2.47e-05	9.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1B1—melanoma	2.47e-05	9.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	2.46e-05	9.56e-05	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—melanoma	2.46e-05	9.55e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CB—melanoma	2.44e-05	9.51e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UGT2B10—melanoma	2.44e-05	9.5e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CD4—melanoma	2.44e-05	9.49e-05	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—melanoma	2.44e-05	9.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	2.43e-05	9.46e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—melanoma	2.38e-05	9.24e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—KRAS—melanoma	2.38e-05	9.24e-05	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—HRAS—melanoma	2.37e-05	9.21e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF2—melanoma	2.37e-05	9.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	2.33e-05	9.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	2.32e-05	9.03e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—STAT3—melanoma	2.29e-05	8.92e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1B—melanoma	2.29e-05	8.92e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—melanoma	2.29e-05	8.9e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCB4—melanoma	2.28e-05	8.87e-05	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—melanoma	2.27e-05	8.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—melanoma	2.27e-05	8.83e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HS3ST5—melanoma	2.27e-05	8.83e-05	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—melanoma	2.27e-05	8.81e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL2—melanoma	2.24e-05	8.73e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MDM2—melanoma	2.21e-05	8.61e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK3—melanoma	2.19e-05	8.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	2.19e-05	8.5e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—melanoma	2.18e-05	8.49e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PIK3CA—melanoma	2.18e-05	8.49e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—melanoma	2.18e-05	8.49e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTNNB1—melanoma	2.17e-05	8.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	2.16e-05	8.4e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CB—melanoma	2.15e-05	8.37e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC6A11—melanoma	2.14e-05	8.34e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIP4K2A—melanoma	2.14e-05	8.34e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1A—melanoma	2.12e-05	8.23e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—melanoma	2.11e-05	8.21e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NFKB1—melanoma	2.1e-05	8.18e-05	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—melanoma	2.09e-05	8.13e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK1—melanoma	2.09e-05	8.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTAP—melanoma	2.09e-05	8.11e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EGFR—melanoma	2.08e-05	8.11e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—melanoma	2.07e-05	8.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	2.04e-05	7.92e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1B—melanoma	2.02e-05	7.86e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—melanoma	2.02e-05	7.86e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—melanoma	2.02e-05	7.86e-05	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—melanoma	2.01e-05	7.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	2e-05	7.78e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—melanoma	1.98e-05	7.7e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL2—melanoma	1.98e-05	7.69e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—melanoma	1.97e-05	7.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	1.95e-05	7.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	1.93e-05	7.52e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—melanoma	1.93e-05	7.52e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—melanoma	1.93e-05	7.52e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCND1—melanoma	1.93e-05	7.5e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—melanoma	1.91e-05	7.42e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—STAT3—melanoma	1.89e-05	7.35e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—melanoma	1.88e-05	7.33e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MMP9—melanoma	1.87e-05	7.28e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1A—melanoma	1.86e-05	7.25e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—melanoma	1.86e-05	7.24e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LUM—melanoma	1.86e-05	7.23e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PHGDH—melanoma	1.86e-05	7.23e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NFKB1—melanoma	1.85e-05	7.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	1.84e-05	7.16e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HPSE—melanoma	1.82e-05	7.09e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—melanoma	1.81e-05	7.04e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK3—melanoma	1.8e-05	7.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CUBN—melanoma	1.79e-05	6.96e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—melanoma	1.78e-05	6.94e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—melanoma	1.78e-05	6.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	1.75e-05	6.8e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SDHD—melanoma	1.73e-05	6.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CSPG4—melanoma	1.73e-05	6.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BSG—melanoma	1.73e-05	6.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	1.72e-05	6.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCB4—melanoma	1.72e-05	6.69e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK1—melanoma	1.72e-05	6.68e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—melanoma	1.72e-05	6.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	1.7e-05	6.6e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—melanoma	1.68e-05	6.54e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—melanoma	1.67e-05	6.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPAM—melanoma	1.67e-05	6.51e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—STAT3—melanoma	1.66e-05	6.47e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—melanoma	1.66e-05	6.46e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	1.66e-05	6.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACER3—melanoma	1.64e-05	6.4e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—melanoma	1.62e-05	6.31e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIP4K2A—melanoma	1.62e-05	6.29e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC6A11—melanoma	1.62e-05	6.29e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—melanoma	1.6e-05	6.23e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK3—melanoma	1.59e-05	6.18e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	1.58e-05	6.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTAP—melanoma	1.57e-05	6.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	1.57e-05	6.11e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MYC—melanoma	1.55e-05	6.01e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	1.54e-05	5.99e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK1—melanoma	1.51e-05	5.88e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—melanoma	1.51e-05	5.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UGT2B10—melanoma	1.5e-05	5.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	1.5e-05	5.83e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—melanoma	1.49e-05	5.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	1.49e-05	5.78e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—melanoma	1.48e-05	5.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	1.45e-05	5.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	1.45e-05	5.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	1.44e-05	5.6e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—melanoma	1.43e-05	5.56e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLA2G6—melanoma	1.42e-05	5.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PHGDH—melanoma	1.4e-05	5.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LUM—melanoma	1.4e-05	5.45e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HS3ST5—melanoma	1.4e-05	5.44e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—melanoma	1.38e-05	5.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HPSE—melanoma	1.38e-05	5.35e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CUBN—melanoma	1.35e-05	5.25e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—melanoma	1.32e-05	5.13e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—melanoma	1.31e-05	5.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	1.31e-05	5.08e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CSPG4—melanoma	1.3e-05	5.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BSG—melanoma	1.3e-05	5.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SDHD—melanoma	1.3e-05	5.07e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—VCAN—melanoma	1.28e-05	4.97e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—melanoma	1.27e-05	4.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPAM—melanoma	1.26e-05	4.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	1.24e-05	4.81e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—melanoma	1.22e-05	4.73e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—melanoma	1.21e-05	4.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	1.2e-05	4.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	1.18e-05	4.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	1.18e-05	4.58e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—melanoma	1.16e-05	4.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.12e-05	4.36e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.11e-05	4.32e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP17A1—melanoma	1.08e-05	4.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLA2G6—melanoma	1.07e-05	4.18e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—melanoma	1.07e-05	4.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCB4—melanoma	1.06e-05	4.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.02e-05	3.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNA11—melanoma	1.02e-05	3.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC6A11—melanoma	9.97e-06	3.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIP4K2A—melanoma	9.97e-06	3.88e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—FASN—melanoma	9.97e-06	3.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	9.88e-06	3.84e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC5A5—melanoma	9.8e-06	3.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTAP—melanoma	9.69e-06	3.77e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—VCAN—melanoma	9.64e-06	3.75e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNAQ—melanoma	9.47e-06	3.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD44—melanoma	9.47e-06	3.68e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1B1—melanoma	9.08e-06	3.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PHGDH—melanoma	8.64e-06	3.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LUM—melanoma	8.64e-06	3.36e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HPSE—melanoma	8.47e-06	3.3e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	8.34e-06	3.24e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CUBN—melanoma	8.32e-06	3.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP17A1—melanoma	8.14e-06	3.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SDHD—melanoma	8.03e-06	3.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BSG—melanoma	8.03e-06	3.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CSPG4—melanoma	8.03e-06	3.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPAM—melanoma	7.78e-06	3.03e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNA11—melanoma	7.68e-06	2.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	7.53e-06	2.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—FASN—melanoma	7.52e-06	2.92e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCB1—melanoma	7.47e-06	2.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A5—melanoma	7.4e-06	2.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNAQ—melanoma	7.14e-06	2.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD44—melanoma	7.14e-06	2.78e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PRKCA—melanoma	6.88e-06	2.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1B1—melanoma	6.85e-06	2.66e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ERCC2—melanoma	6.82e-06	2.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLA2G6—melanoma	6.62e-06	2.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—VCAN—melanoma	5.94e-06	2.31e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CG—melanoma	5.39e-06	2.1e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—melanoma	5.2e-06	2.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PRKCA—melanoma	5.19e-06	2.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ERCC2—melanoma	5.15e-06	2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP17A1—melanoma	5.01e-06	1.95e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CD—melanoma	4.74e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNA11—melanoma	4.73e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—melanoma	4.68e-06	1.82e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—FASN—melanoma	4.63e-06	1.8e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A5—melanoma	4.56e-06	1.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNAQ—melanoma	4.4e-06	1.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD44—melanoma	4.4e-06	1.71e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1B1—melanoma	4.22e-06	1.64e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CB—melanoma	4.13e-06	1.61e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—melanoma	4.09e-06	1.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CG—melanoma	4.07e-06	1.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—melanoma	3.92e-06	1.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CD—melanoma	3.57e-06	1.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—melanoma	3.57e-06	1.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—melanoma	3.53e-06	1.37e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCB1—melanoma	3.47e-06	1.35e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PRKCA—melanoma	3.2e-06	1.24e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ERCC2—melanoma	3.17e-06	1.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CB—melanoma	3.12e-06	1.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—melanoma	3.09e-06	1.2e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—melanoma	2.69e-06	1.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—melanoma	2.52e-06	9.79e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CG—melanoma	2.5e-06	9.74e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—melanoma	2.42e-06	9.4e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CD—melanoma	2.2e-06	8.56e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—melanoma	2.17e-06	8.45e-06	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—melanoma	2.06e-06	8e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CB—melanoma	1.92e-06	7.46e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—melanoma	1.9e-06	7.4e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—melanoma	1.9e-06	7.39e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—melanoma	1.66e-06	6.45e-06	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—melanoma	1.55e-06	6.03e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—melanoma	1.17e-06	4.55e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—melanoma	9.56e-07	3.72e-06	CbGpPWpGaD
